rlclark
6 minutes ago
Blarcamesine sustains benefits in early Alzheimer’s patients over year
Oral therapy found to slow cognitive, functional decline in Phase 2b/3 trial
Margarida Maia, PhD avatar
by Margarida Maia, PhD | August 1, 2024
A person presents charts in front of a cr